NIH officials have announced that after 2020, they don’t plan to fund topical HIV prevention products like douches or gels, unless they can protect the whole body, or unless early studies have shown they can substantially reduce HIV risk.
By Heather Boerner
Truvada was first approved for preventive use in the United States in 2012, and has been shown to significantly reduce the chance of infection.
By Donato Paolo Mancini, STAT
NewsHour's John Carlos Frey reports in this updated segment on San Francisco's plan to zero out the number of new HIV infections. The city's public health officials, doctors, and activists have made huge strides battling the epidemic and are now…
By PBS NewsHour
In California, New York, Texas and elsewhere, health workers are trying to get more high-risk Latino men to use the drug, Truvada. The medication, which is used for “Pre-Exposure Prophylaxis” or PrEP, was approved by the FDA in 2012 for…
By Anna Gorman, Kaiser Health News
By Daniel Costa-Roberts
Truvada can be used for what is called "PrEP," short for "pre-exposure prophylaxis," the controversial practice of using antiretroviral drugs to prevent HIV infection.
A Drug to Prevent HIV's Spread: Truvada's Promises and Problems…
Spencer Michels profiles the company that makes the HIV medicine, and the strides to make it affordable to those in the U.S. and poorer countries.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.